Kahira Pharmaceuticals & Chemical Industries Co. (CPCI) Key Statistics
19 reported figures for Kahira Pharmaceuticals & Chemical Industries Co. — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 8.04B
- Dividend yield
- 3.11%
Income (latest fiscal year)
- Revenue
- EGP 962.94M
- Net income
- EGP 85.17M
- EBITDA
- EGP 129.9M
- Free cash flow
- EGP 117.39M
Balance sheet
- Total assets
- EGP 1.06B
- Total debt
- EGP 0
Growth
- Revenue growth
- 11.59%
- Profit growth
- -21.47%
- EPS growth
- -21.47%
Per share
- EPS (fiscal year)
- 5.7
- Dividend per share
- 2
Technical
- RSI (14)
- 58.9
- 50-day moving average
- EGP 492.86
- 200-day moving average
- EGP 338.95
- Beta (1Y)
- 0.11
Shares
- Shares outstanding
- 14.93M
- Free float
- 30%
Source: company disclosures to the Egyptian Exchange via TradingView. Fiscal-year figures are as last reported; technical readings refresh with market data.